CD34 and Miyoshi myopathy: One of the earliest and most detailed reports used CD34+ HSPCs-derived allogeneic NK cells transduced with a retroviral vector carrying second generation CD38-specific CAR (PNK-CAR38 cells), which showed significant cytotoxic activity against MM cell lines both in vitro and in a disseminated lymphoma murine xenograft model [102].